{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:22:51Z","timestamp":1793902971857,"version":"4.8.0"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773334"],"award-info":[{"award-number":["81773334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003364"],"award-info":[{"award-number":["82003364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2018RS3031"],"award-info":[{"award-number":["2018RS3031"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011496","name":"Science and Technology\u00a0Bureau, Changsha","doi-asserted-by":"publisher","award":["kq1802002"],"award-info":[{"award-number":["kq1802002"]}],"id":[{"id":"10.13039\/501100011496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12016-021-08886-x","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T10:03:41Z","timestamp":1631786621000},"page":"424-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management"],"prefix":"10.1007","volume":"61","author":[{"given":"Liting","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-1486","authenticated-orcid":false,"given":"Hai","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"issue":"2","key":"8886_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/all.14037","volume":"75","author":"J Fricke","year":"2020","unstructured":"Fricke J, \u00c1vila G, Keller T et al (2020) Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy 75(2):423\u2013432. https:\/\/doi.org\/10.1111\/all.14037","journal-title":"Allergy"},{"issue":"7","key":"8886_CR2","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/all.13397","volume":"73","author":"T Zuberbier","year":"2018","unstructured":"Zuberbier T, Aberer W, Asero R et al (2018) The EAACI\/GA2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 73(7):1393\u20131414. https:\/\/doi.org\/10.1111\/all.13397","journal-title":"Allergy"},{"issue":"1","key":"8886_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.alit.2018.05.011","volume":"68","author":"S Eun","year":"2019","unstructured":"Eun S, Lee J, Kim D et al (2019) Natural course of new-onset urticaria: results of a 10-year follow-up, nationwide, population-based study. Allergology international: Official Journal of the Japanese Society of Allergology 68(1):52\u201358. https:\/\/doi.org\/10.1016\/j.alit.2018.05.011","journal-title":"Allergology international: Official Journal of the Japanese Society of Allergology"},{"key":"8886_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19561","author":"M Gon\u00e7alo","year":"2020","unstructured":"Gon\u00e7alo M, Gimen\u00e9z-Arnau A, Al-Ahmad M et al (2020) The global burden of chronic urticaria for the patient and society. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.19561","journal-title":"Br J Dermatol"},{"issue":"1","key":"8886_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jaad.2019.02.034","volume":"81","author":"Y Rosman","year":"2019","unstructured":"Rosman Y, Hershko A, Meir-Shafrir K et al (2019) Characterization of chronic urticaria and associated conditions in a large population of adolescents. J Am Acad Dermatol 81(1):129\u2013135. https:\/\/doi.org\/10.1016\/j.jaad.2019.02.034","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"8886_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/imr.12632","volume":"282","author":"M Church","year":"2018","unstructured":"Church M, Kolkhir P, Metz M et al (2018) The role and relevance of mast cells in urticaria. Immunol Rev 282(1):232\u2013247. https:\/\/doi.org\/10.1111\/imr.12632","journal-title":"Immunol Rev"},{"issue":"1","key":"8886_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12016-017-8628-1","volume":"54","author":"S Radonjic-Hoesli","year":"2018","unstructured":"Radonjic-Hoesli S, Hofmeier K, Micaletto S et al (2018) Urticaria and angioedema: an update on classification and pathogenesis. Clin Rev Allergy Immunol 54(1):88\u2013101. https:\/\/doi.org\/10.1007\/s12016-017-8628-1","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"8886_CR8","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1111\/all.13949","volume":"74","author":"N Schoepke","year":"2019","unstructured":"Schoepke N, Asero R, Ellrich A et al (2019) Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: results of the PURIST Study. Allergy 74(12):2427\u20132436. https:\/\/doi.org\/10.1111\/all.13949","journal-title":"Allergy"},{"issue":"1","key":"8886_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12016-012-8326-y","volume":"45","author":"K Altman","year":"2013","unstructured":"Altman K, Chang C (2013) Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema. Clin Rev Allergy Immunol 45(1):47\u201362. https:\/\/doi.org\/10.1007\/s12016-012-8326-y","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"8886_CR10","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1172\/jci85538","volume":"126","author":"N Gaudenzio","year":"2016","unstructured":"Gaudenzio N, Sibilano R, Marichal T et al (2016) Different activation signals induce distinct mast cell degranulation strategies. J Clin Investig 126(10):3981\u20133998. https:\/\/doi.org\/10.1172\/jci85538","journal-title":"J Clin Investig"},{"issue":"5","key":"8886_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1365-2133.1986.tb04065.x","volume":"114","author":"C Grattan","year":"1986","unstructured":"Grattan C, Wallington T, Warin R et al (1986) A serological mediator in chronic idiopathic urticaria\u2013a clinical, immunological and histological evaluation. Br J Dermatol 114(5):583\u2013590. https:\/\/doi.org\/10.1111\/j.1365-2133.1986.tb04065.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"8886_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1067\/mai.2001.117792","volume":"108","author":"A Tedeschi","year":"2001","unstructured":"Tedeschi A, Lorini M, Asero R (2001) Anti-thyroid peroxidase IgE in patients with chronic urticaria. J Allergy Clin Immunol 108(3):467\u2013468. https:\/\/doi.org\/10.1067\/mai.2001.117792","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8886_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014794","volume":"6","author":"S Altrichter","year":"2011","unstructured":"Altrichter S, Peter H, Pisarevskaja D et al (2011) IgE mediated autoallergy against thyroid peroxidase\u2013a novel pathomechanism of chronic spontaneous urticaria? PLoS One 6(4)","journal-title":"PLoS One"},{"key":"8886_CR14","doi-asserted-by":"publisher","unstructured":"Hatada Y, Kashiwakura J, Hayama K et al (2013) Significantly high levels of anti-dsDNA immunoglobulin E in sera and the ability of dsDNA to induce the degranulation of basophils from chronic urticaria patients. Int Arch Allergy Immunol 161(Suppl 2):154\u2013158.\u00a0https:\/\/doi.org\/10.1159\/000350388","DOI":"10.1159\/000350388"},{"issue":"3","key":"8886_CR15","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jaci.2017.10.035","volume":"142","author":"O Schmetzer","year":"2018","unstructured":"Schmetzer O, Lakin E, Topal F et al (2018) IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. J Allergy Clin Immunol 142(3):876\u2013882. https:\/\/doi.org\/10.1016\/j.jaci.2017.10.035","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"8886_CR16","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1111\/all.13832","volume":"74","author":"L de Montjoye","year":"2019","unstructured":"de Montjoye L, Herman A, Hendrickx E et al (2019) Increased expression of IL-24 in chronic spontaneous urticaria. Allergy 74(9):1811\u20131813. https:\/\/doi.org\/10.1111\/all.13832","journal-title":"Allergy"},{"key":"8886_CR17","doi-asserted-by":"publisher","unstructured":"Yu L, Buttgereit T, Stahl Skov P et al (2019) Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria. J Eur Acad Dermatol Venereol 33(9):1747\u20131754.\u00a0https:\/\/doi.org\/10.1111\/jdv.15640","DOI":"10.1111\/jdv.15640"},{"key":"8886_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3389\/fimmu.2018.00689","volume":"9","author":"M Maurer","year":"2018","unstructured":"Maurer M, Altrichter S, Schmetzer O et al (2018) Immunoglobulin E-mediated autoimmunity Frontiers in immunology 9:689. https:\/\/doi.org\/10.3389\/fimmu.2018.00689","journal-title":"Immunoglobulin E-mediated autoimmunity Frontiers in immunology"},{"issue":"2","key":"8886_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41385-020-00336-9","volume":"14","author":"J Schanin","year":"2021","unstructured":"Schanin J, Gebremeskel S, Korver W et al (2021)\u00a0A monoclonal antibody to Siglec-8 suppresses non-allergic airway\u00a0inflammation and inhibits IgE-independent mast cell activation. Mucosal Immunol 14(2):366\u2013376. https:\/\/doi.org\/10.1038\/s41385-020-00336-9","journal-title":"Mucosal Immunol"},{"issue":"2","key":"8886_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/all.13567","volume":"74","author":"S Mo\u00f1ino-Romero","year":"2019","unstructured":"Mo\u00f1ino-Romero S, Erkert L, Schmidthaler K et al (2019) The soluble isoform of human Fc\u025bRI is an endogenous inhibitor of IgE-mediated mast cell responses. Allergy 74(2):236\u2013245. https:\/\/doi.org\/10.1111\/all.13567","journal-title":"Allergy"},{"issue":"3","key":"8886_CR21","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jaci.2018.05.019","volume":"143","author":"D MacGlashan","year":"2019","unstructured":"MacGlashan D (2019) Autoantibodies to IgE and Fc\u03b5RI and the natural variability of spleen tyrosine kinase expression in basophils. J Allergy Clin Immunol 143(3):1100-1107.e1111. https:\/\/doi.org\/10.1016\/j.jaci.2018.05.019","journal-title":"J Allergy Clin Immunol"},{"key":"8886_CR22","doi-asserted-by":"publisher","unstructured":"Fiebiger E, Hammerschmid F, Stingl G et al (1998) Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 101(1):243\u2013251.\u00a0https:\/\/doi.org\/10.1172\/jci511","DOI":"10.1172\/jci511"},{"issue":"1","key":"8886_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1067\/mai.2002.120954","volume":"109","author":"Y Kikuchi","year":"2002","unstructured":"Kikuchi Y, Kaplan A (2002) A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 109(1):114\u2013118. https:\/\/doi.org\/10.1067\/mai.2002.120954","journal-title":"J Allergy Clin Immunol"},{"key":"8886_CR24","doi-asserted-by":"publisher","unstructured":"Sch\u00e4fer B, Piliponsky A, Oka T et al (2013) Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J Allergy Clin Immunol 131(2):541\u2013548.e1\u20139. https:\/\/doi.org\/10.1016\/j.jaci.2012.05.009","DOI":"10.1016\/j.jaci.2012.05.009"},{"issue":"12","key":"8886_CR25","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1111\/j.1365-2222.2005.02380.x","volume":"35","author":"A Puccetti","year":"2005","unstructured":"Puccetti A, Bason C, Simeoni S et al (2005) In chronic idiopathic urticaria autoantibodies against Fc epsilonRII\/CD23 induce histamine release via eosinophil activation. Clinical and experimental allergy: Journal of the British Society for Allergy and Clinical Immunology 35(12):1599\u20131607. https:\/\/doi.org\/10.1111\/j.1365-2222.2005.02380.x","journal-title":"Clinical and experimental allergy: Journal of the British Society for Allergy and Clinical Immunology"},{"issue":"6","key":"8886_CR26","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1067\/mai.2001.114656","volume":"107","author":"A Piliponsky","year":"2001","unstructured":"Piliponsky A, Pickholtz D, Gleich G et al (2001) Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. J Allergy Clin Immunol 107(6):993\u20131000. https:\/\/doi.org\/10.1067\/mai.2001.114656","journal-title":"J Allergy Clin Immunol"},{"key":"8886_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/all.14412","author":"S Altrichter","year":"2020","unstructured":"Altrichter S, Zampeli V, Ellrich A et al (2020) IgM and IgA in addition to IgG autoantibodies against Fc\u025bRI\u03b1 are frequent and associated with disease markers of chronic spontaneous urticaria. Allergy. https:\/\/doi.org\/10.1111\/all.14412","journal-title":"Allergy"},{"issue":"3","key":"8886_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jaci.2016.04.036","volume":"138","author":"P Auyeung","year":"2016","unstructured":"Auyeung P, Mittag D, Hodgkin P et al (2016) Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor I\u03b1 subunit. J Allergy Clin Immunol 138(3):761-768.e764. https:\/\/doi.org\/10.1016\/j.jaci.2016.04.036","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"8886_CR29","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.autrev.2017.10.003","volume":"16","author":"P Kolkhir","year":"2017","unstructured":"Kolkhir P, Borzova E, Grattan C et al (2017) Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review. Autoimmun Rev 16(12):1196\u20131208. https:\/\/doi.org\/10.1016\/j.autrev.2017.10.003","journal-title":"Autoimmun Rev"},{"issue":"10","key":"8886_CR30","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/j.1398-9995.2012.02879.x","volume":"67","author":"Y Okayama","year":"2012","unstructured":"Okayama Y, Kashiwakura J, Matsuda A et al (2012) The interaction between Lyn and Fc\u03b5RI\u03b2 is indispensable for Fc\u03b5RI-mediated human mast cell activation. Allergy 67(10):1241\u20131249. https:\/\/doi.org\/10.1111\/j.1398-9995.2012.02879.x","journal-title":"Allergy"},{"issue":"2","key":"8886_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/all.12786","volume":"71","author":"X Li","year":"2016","unstructured":"Li X, Kwon O, Kim D et al (2016) NecroX-5 suppresses IgE\/Ag-stimulated anaphylaxis and mast cell activation by regulating the SHP-1-Syk signaling module. Allergy 71(2):198\u2013209. https:\/\/doi.org\/10.1111\/all.12786","journal-title":"Allergy"},{"issue":"1","key":"8886_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1600-065X.2008.00742.x","volume":"228","author":"A Gilfillan","year":"2009","unstructured":"Gilfillan A, Rivera J (2009) The tyrosine kinase network regulating mast cell activation. Immunol Rev 228(1):149\u2013169. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00742.x","journal-title":"Immunol Rev"},{"issue":"2","key":"8886_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jaci.2007.08.051","volume":"121","author":"E Mertsching","year":"2008","unstructured":"Mertsching E, Bafetti L, Hess H et al (2008) A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases. J Allergy Clin Immunol 121(2):441-447.e445. https:\/\/doi.org\/10.1016\/j.jaci.2007.08.051","journal-title":"J Allergy Clin Immunol"},{"key":"8886_CR34","doi-asserted-by":"publisher","unstructured":"Saini S, Paterniti M, Vasagar K et al (2009) Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: relationship to expression of Syk and SHIP-2. Clin Immunol 132(3):342\u2013348. https:\/\/doi.org\/10.1016\/j.clim.2009.05.003","DOI":"10.1016\/j.clim.2009.05.003"},{"key":"8886_CR35","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fimmu.2019.00627","volume":"10","author":"S Bracken","year":"2019","unstructured":"Bracken S, Abraham S, MacLeod A (2019) Autoimmune theories of chronic spontaneous urticaria. Front Immunol 10:627. https:\/\/doi.org\/10.3389\/fimmu.2019.00627","journal-title":"Front Immunol"},{"issue":"5","key":"8886_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jaci.2005.12.1343","volume":"117","author":"R Asero","year":"2006","unstructured":"Asero R, Tedeschi A, Riboldi P et al (2006) Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 117(5):1113\u20131117. https:\/\/doi.org\/10.1016\/j.jaci.2005.12.1343","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8886_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jaci.2006.08.043","volume":"119","author":"R Asero","year":"2007","unstructured":"Asero R, Tedeschi A, Coppola R et al (2007) Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol 119(3):705\u2013710. https:\/\/doi.org\/10.1016\/j.jaci.2006.08.043","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8886_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1398-9995.2009.02222.x","volume":"65","author":"S Takahagi","year":"2010","unstructured":"Takahagi S, Mihara S, Iwamoto K et al (2010) Coagulation\/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy 65(5):649\u2013656. https:\/\/doi.org\/10.1111\/j.1398-9995.2009.02222.x","journal-title":"Allergy"},{"key":"8886_CR39","doi-asserted-by":"publisher","unstructured":"Ghazanfar M, Thomsen S (2018) D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review. Eur J Dermatol 28(6):731\u2013735. https:\/\/doi.org\/10.1684\/ejd.2018.3443","DOI":"10.1684\/ejd.2018.3443"},{"issue":"1","key":"8886_CR40","first-page":"43","volume":"31","author":"H Zhu","year":"2013","unstructured":"Zhu H, Liang B, Li R et al (2013) Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol 31(1):43\u201350","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"2","key":"8886_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000155748","volume":"148","author":"M Cugno","year":"2009","unstructured":"Cugno M, Marzano A, Tedeschi A et al (2009) Expression of tissue factor by eosinophils in patients with chronic urticaria. Int Arch Allergy Immunol 148(2):170\u2013174. https:\/\/doi.org\/10.1159\/000155748","journal-title":"Int Arch Allergy Immunol"},{"key":"8886_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.018","author":"Y Yanase","year":"2020","unstructured":"Yanase Y, Matsuo Y, Takahagi S et al (2020) Coagulation factors induce human skin mast cell and basophil degranulation via activation of complement 5 and the C5a receptor. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2020.08.018","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8886_CR43","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/s0091-6749(99)70190-9","volume":"103","author":"U Fagiolo","year":"1999","unstructured":"Fagiolo U, Cancian M, Bertollo L et al (1999) Inhibitory effect of heparin on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 103(6):1143\u20131147. https:\/\/doi.org\/10.1016\/s0091-6749(99)70190-9","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8886_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11739-009-0333-5","volume":"5","author":"M Cugno","year":"2010","unstructured":"Cugno M, Marzano A, Asero R et al (2010) Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications. Intern Emerg Med 5(2):97\u2013101. https:\/\/doi.org\/10.1007\/s11739-009-0333-5","journal-title":"Intern Emerg Med"},{"key":"8886_CR45","doi-asserted-by":"publisher","unstructured":"Sindher S, Jariwala S, Gilbert J et al (2012) Resolution of chronic urticaria coincident with vitamin D supplementation. Ann Allergy Asthma Immunol 109(5):359\u2013360. https:\/\/doi.org\/10.1016\/j.anai.2012.07.025","DOI":"10.1016\/j.anai.2012.07.025"},{"key":"8886_CR46","doi-asserted-by":"publisher","unstructured":"Wu Y, Cai Y, Liu M et al (2020) The potential immunoregulatory roles of vitamin D in neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 43:102156. https:\/\/doi.org\/10.1016\/j.msard.2020.102156","DOI":"10.1016\/j.msard.2020.102156"},{"issue":"3","key":"8886_CR47","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jaad.2018.02.033","volume":"79","author":"T Tsai","year":"2018","unstructured":"Tsai T, Huang Y (2018) Vitamin D deficiency in patients with chronic and acute urticaria: a systematic review and meta-analysis. J Am Acad Dermatol 79(3):573\u2013575. https:\/\/doi.org\/10.1016\/j.jaad.2018.02.033","journal-title":"J Am Acad Dermatol"},{"key":"8886_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13601-018-0234-7","volume":"8","author":"P Tuchinda","year":"2018","unstructured":"Tuchinda P, Kulthanan K, Chularojanamontri L et al (2018) Relationship between vitamin D and chronic spontaneous urticaria: a systematic review. Clinical and translational allergy 8:51. https:\/\/doi.org\/10.1186\/s13601-018-0234-7","journal-title":"Clinical and translational allergy"},{"issue":"8","key":"8886_CR49","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/all.13110","volume":"72","author":"Z Liu","year":"2017","unstructured":"Liu Z, Li X, Qiu S et al (2017) Vitamin D contributes to mast cell stabilization. Allergy 72(8):1184\u20131192. https:\/\/doi.org\/10.1111\/all.13110","journal-title":"Allergy"},{"key":"8886_CR50","doi-asserted-by":"publisher","unstructured":"Zhao J, Ping J, Wang Y et al (2020) Vitamin D suppress the production of vascular endothelial growth factor in mast cell by inhibiting PI3K\/Akt\/p38 MAPK\/HIF-1\u03b1 pathway in chronic spontaneous urticaria. Clin Immunol 215:108444. https:\/\/doi.org\/10.1016\/j.clim.2020.108444","DOI":"10.1016\/j.clim.2020.108444"},{"issue":"4","key":"8886_CR51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/ACI.0b013e32833c79d7","volume":"10","author":"A Shakouri","year":"2010","unstructured":"Shakouri A, Compalati E, Lang D et al (2010) Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system. Curr Opin Allergy Clin Immunol 10(4):362\u2013369. https:\/\/doi.org\/10.1097\/ACI.0b013e32833c79d7","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"8886_CR52","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40257-015-0152-6","volume":"16","author":"H Curth","year":"2015","unstructured":"Curth H, Dinter J, Nigemeier K et al (2015) Effects of Helicobacter pylori eradication in chronic spontaneous urticaria: results from a retrospective cohort study. Am J Clin Dermatol 16(6):553\u2013558. https:\/\/doi.org\/10.1007\/s40257-015-0152-6","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"8886_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12661","volume":"24","author":"H Kim","year":"2019","unstructured":"Kim H, Kim Y, Lee H et al (2019) Systematic review and meta-analysis: effect of Helicobacter pylori eradication on chronic spontaneous urticaria. Helicobacter 24(6):e12661. https:\/\/doi.org\/10.1111\/hel.12661","journal-title":"Helicobacter"},{"issue":"6","key":"8886_CR54","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/hel.12312","volume":"21","author":"R Tan","year":"2016","unstructured":"Tan R, Sun H, Zhang W et al (2016) A 21\u201335 kDa mixed protein component from Helicobacter pylori activates mast cells effectively in chronic spontaneous urticaria. Helicobacter 21(6):565\u2013574. https:\/\/doi.org\/10.1111\/hel.12312","journal-title":"Helicobacter"},{"key":"8886_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00561-9","author":"C Chen","year":"2020","unstructured":"Chen C, Huang W, Chang L et al (2020) Peptic ulcer disease is associated with increased risk of chronic urticaria independent of Helicobacter pylori infection: a population-based cohort study. Am J Clin Dermatol. https:\/\/doi.org\/10.1007\/s40257-020-00561-9","journal-title":"Am J Clin Dermatol"},{"issue":"7","key":"8886_CR56","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/all.13381","volume":"73","author":"S Altrichter","year":"2018","unstructured":"Altrichter S, Hawro T, Liedtke M et al (2018) In chronic spontaneous urticaria, IgE against staphylococcal enterotoxins is common and functional. Allergy 73(7):1497\u20131504. https:\/\/doi.org\/10.1111\/all.13381","journal-title":"Allergy"},{"issue":"1","key":"8886_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1365-2133.2009.09411.x","volume":"162","author":"A Bellanger","year":"2010","unstructured":"Bellanger A, Humbert P, Gavignet B et al (2010) Comparative assessment of enzyme-linked immunosorbent assay and Western blot for the diagnosis of toxocariasis in patients with skin disorders. Br J Dermatol 162(1):80\u201382. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09411.x","journal-title":"Br J Dermatol"},{"issue":"10","key":"8886_CR58","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/all.13482","volume":"73","author":"P Kolkhir","year":"2018","unstructured":"Kolkhir P, Pereverzina N, Olisova O et al (2018) Comorbidity of viral hepatitis and chronic spontaneous urticaria: a systematic review. Allergy 73(10):1946\u20131953. https:\/\/doi.org\/10.1111\/all.13482","journal-title":"Allergy"},{"issue":"3","key":"8886_CR59","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","volume":"138","author":"H Subramanian","year":"2016","unstructured":"Subramanian H, Gupta K, Ali H (2016) Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. J Allergy Clin Immunol 138(3):700\u2013710. https:\/\/doi.org\/10.1016\/j.jaci.2016.04.051","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8886_CR60","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","volume":"134","author":"D Fujisawa","year":"2014","unstructured":"Fujisawa D, Kashiwakura J, Kita H et al (2014) Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. J Allergy Clin Immunol 134(3):622-633.e629. https:\/\/doi.org\/10.1016\/j.jaci.2014.05.004","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8886_CR61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/all.14015","volume":"75","author":"C Schut","year":"2020","unstructured":"Schut C, Magerl M, Hawro T et al (2020) Disease activity and stress are linked in a subpopulation of chronic spontaneous urticaria patients. Allergy 75(1):224\u2013226. https:\/\/doi.org\/10.1111\/all.14015","journal-title":"Allergy"},{"key":"8886_CR62","doi-asserted-by":"publisher","unstructured":"Konstantinou G, Konstantinou G (2020) Psychological stress and chronic urticaria: a neuro-immuno-cutaneous crosstalk. A systematic review of the existing evidence. Clin Ther 42(5):771\u2013782. https:\/\/doi.org\/10.1016\/j.clinthera.2020.03.010","DOI":"10.1016\/j.clinthera.2020.03.010"},{"issue":"4","key":"8886_CR63","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2332\/allergolint.13-OA-0536","volume":"62","author":"H Matsuo","year":"2013","unstructured":"Matsuo H, Yokooji T, Morita H et al (2013) Aspirin augments IgE-mediated histamine release from human peripheral basophils via Syk kinase activation. Allergology international: Official Journal of the Japanese Society of Allergology 62(4):503\u2013511. https:\/\/doi.org\/10.2332\/allergolint.13-OA-0536","journal-title":"Allergology international: Official Journal of the Japanese Society of Allergology"},{"key":"8886_CR64","doi-asserted-by":"publisher","unstructured":"Shi C, Li Y, Luo Y et al (2012) IgE-mediated allergy: a rare cause of chronic spontaneous urticarial with allergen-specific immunotherapy as treatment option-a systematic review with meta-analysis from China. J Eur Acad Dermatol Venereol 26(5):533\u2013544. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04302.x","DOI":"10.1111\/j.1468-3083.2011.04302.x"},{"issue":"2","key":"8886_CR65","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1067\/mai.2002.121309","volume":"109","author":"T Zuberbier","year":"2002","unstructured":"Zuberbier T, Pfrommer C, Specht K et al (2002) Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. J Allergy Clin Immunol 109(2):343\u2013348. https:\/\/doi.org\/10.1067\/mai.2002.121309","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8886_CR66","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000339332","volume":"224","author":"Z Brzoza","year":"2012","unstructured":"Brzoza Z, Grzeszczak W, Rogala B et al (2012) PTPN22 polymorphism presumably plays a role in the genetic background of chronic spontaneous autoreactive urticaria. Dermatology (Basel, Switzerland) 224(4):340\u2013345. https:\/\/doi.org\/10.1159\/000339332","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"5","key":"8886_CR67","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/bjd.13621","volume":"172","author":"A Kay","year":"2015","unstructured":"Kay A, Clark P, Maurer M et al (2015) Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (\u2018idiopathic\u2019) urticaria. Br J Dermatol 172(5):1294\u20131302. https:\/\/doi.org\/10.1111\/bjd.13621","journal-title":"Br J Dermatol"},{"issue":"4","key":"8886_CR68","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.molimm.2010.10.010","volume":"48","author":"K Feuser","year":"2011","unstructured":"Feuser K, Feilhauer K, Staib L et al (2011) Akt cross-links IL-4 priming, stem cell factor signaling, and IgE-dependent activation in mature human mast cells. Mol Immunol 48(4):546\u2013552. https:\/\/doi.org\/10.1016\/j.molimm.2010.10.010","journal-title":"Mol Immunol"},{"issue":"1","key":"8886_CR69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000496162","volume":"179","author":"E Oliver","year":"2019","unstructured":"Oliver E, Chichester K, Devine K et al (2019) Effects of an oral CRTh2 antagonist (AZD1981) on eosinophil activity and symptoms in chronic spontaneous urticaria. Int Arch Allergy Immunol 179(1):21\u201330. https:\/\/doi.org\/10.1159\/000496162","journal-title":"Int Arch Allergy Immunol"},{"issue":"12","key":"8886_CR70","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1111\/all.13586","volume":"73","author":"K Weller","year":"2018","unstructured":"Weller K, Ohanyan T, Hawro T et al (2018) Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab. Allergy 73(12):2406\u20132408. https:\/\/doi.org\/10.1111\/all.13586","journal-title":"Allergy"},{"issue":"5","key":"8886_CR71","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","volume":"133","author":"JA Bernstein","year":"2014","unstructured":"Bernstein JA, Lang DM, Khan DA et al (2014) The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol 133(5):1270\u20131277. https:\/\/doi.org\/10.1016\/j.jaci.2014.02.036","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8886_CR72","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/bjd.14768","volume":"175","author":"S Guill\u00e9n-Aguinaga","year":"2016","unstructured":"Guill\u00e9n-Aguinaga S, J\u00e1uregui Presa I, Aguinaga-Ontoso E et al (2016) Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis. Br J Dermatol 175(6):1153\u20131165. https:\/\/doi.org\/10.1111\/bjd.14768","journal-title":"Br J Dermatol"},{"issue":"6","key":"8886_CR73","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/bjd.15104","volume":"175","author":"K Weller","year":"2016","unstructured":"Weller K, Maurer M (2016) Antihistamine updosing in chronic urticaria - is there enough evidence? Br J Dermatol 175(6):1134\u20131135. https:\/\/doi.org\/10.1111\/bjd.15104","journal-title":"Br J Dermatol"},{"issue":"3","key":"8886_CR74","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jdermsci.2019.05.008","volume":"94","author":"M Hide","year":"2019","unstructured":"Hide M, Suzuki T, Tanaka A et al (2019) Long-term safety and efficacy of rupatadine in Japanese patients with itching due to chronic spontaneous urticaria, dermatitis, or pruritus: a 12-month, multicenter, open-label clinical trial. J Dermatol Sci 94(3):339\u2013345. https:\/\/doi.org\/10.1016\/j.jdermsci.2019.05.008","journal-title":"J Dermatol Sci"},{"issue":"7","key":"8886_CR75","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2340\/00015555-2941","volume":"98","author":"L Curto-Barredo","year":"2018","unstructured":"Curto-Barredo L, Archilla L, Vives G et al (2018) Clinical features of chronic spontaneous urticaria that predict disease prognosis and refractoriness to standard treatment. Acta Derm Venereol 98(7):641\u2013647. https:\/\/doi.org\/10.2340\/00015555-2941","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"8886_CR76","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.jaci.2013.04.037","volume":"132","author":"R Asero","year":"2013","unstructured":"Asero R (2013) D-dimer: a biomarker for antihistamine-resistant chronic urticaria. J Allergy Clin Immunol 132(4):983\u2013986. https:\/\/doi.org\/10.1016\/j.jaci.2013.04.037","journal-title":"J Allergy Clin Immunol"},{"key":"8886_CR77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13601-019-0275-6","volume":"9","author":"B Ulambayar","year":"2019","unstructured":"Ulambayar B, Yang E, Cha H et al (2019) Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study. Clinical and translational allergy 9:33. https:\/\/doi.org\/10.1186\/s13601-019-0275-6","journal-title":"Clinical and translational allergy"},{"key":"8886_CR78","doi-asserted-by":"publisher","unstructured":"Kolkhir P, Church MK, Altrichter S et al. (2020) Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity, and poor response to treatment. J Allergy Clin Immunol Pract 8(1):318\u2013325 e315. https:\/\/doi.org\/10.1016\/j.jaip.2019.08.025","DOI":"10.1016\/j.jaip.2019.08.025"},{"issue":"4","key":"8886_CR79","doi-asserted-by":"publisher","first-page":"189","DOI":"10.23822\/eurannaci.1764-1489.05","volume":"49","author":"P Kolkhir","year":"2017","unstructured":"Kolkhir P, Pogorelov D, Olisova O (2017) CRP, D-dimer, fibrinogen and ESR as predictive markers of response to standard doses of levocetirizine in patients with chronic spontaneous urticaria. Eur Ann Allergy Clin Immunol 49(4):189\u2013192. https:\/\/doi.org\/10.23822\/eurannaci.1764-1489.05","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"4","key":"8886_CR80","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jaci.2016.10.017","volume":"139","author":"J Li","year":"2017","unstructured":"Li J, Guo A, Chen W et al (2017) Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine. J Allergy Clin Immunol 139(4):1386-1388.e1389. https:\/\/doi.org\/10.1016\/j.jaci.2016.10.017","journal-title":"J Allergy Clin Immunol"},{"key":"8886_CR81","doi-asserted-by":"publisher","unstructured":"Yan J, Li Q, Luo Y et al (2018) [Association of CACNA1C gene genetic polymorphism with the susceptibility as well as prognosis for chronic spontaneous urticaria] (Article in Chinese). Zhong Nan Da Xue Xue Bao Yi Xue Ban (Journal of Central South University Medical sciences) 43(9):929\u2013936. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2018.09.001","DOI":"10.11817\/j.issn.1672-7347.2018.09.001"},{"issue":"3","key":"8886_CR82","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/exd.13874","volume":"28","author":"S Yan","year":"2019","unstructured":"Yan S, Chen W, Peng C et al (2019) C-reactive protein (CRP) rs3093059C predicts poor mizolastine response in chronic spontaneous urticaria patients with elevated serum CRP level. Exp Dermatol 28(3):240\u2013246. https:\/\/doi.org\/10.1111\/exd.13874","journal-title":"Exp Dermatol"},{"issue":"6","key":"8886_CR83","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jaad.2020.02.041","volume":"82","author":"S Gabrielli","year":"2020","unstructured":"Gabrielli S, Le M, Netchiporouk E et al (2020) Chronic urticaria in children can be controlled effectively with updosing second-generation antihistamines. J Am Acad Dermatol 82(6):1535\u20131537. https:\/\/doi.org\/10.1016\/j.jaad.2020.02.041","journal-title":"J Am Acad Dermatol"},{"key":"8886_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13325","author":"L Sarti","year":"2020","unstructured":"Sarti L, Barni S, Giovannini M et al (2020) Efficacy and tolerability of the updosing of second-generation non-sedating H1 antihistamines in children with chronic spontaneous urticaria. Pediatr Allergy Immunol. https:\/\/doi.org\/10.1111\/pai.13325","journal-title":"Pediatr Allergy Immunol"},{"key":"8886_CR85","doi-asserted-by":"publisher","unstructured":"Saito J, Yakuwa N, Sandaiji N et al (2020) Ebastine during pregnancy and lactation in a patient with chronic urticaria: ebastine and carebastine levels in maternal serum, cord blood, breast milk and the infant\u2019s serum. J Eur Acad Dermatol Venereol 34(9):e496\u2013e497. https:\/\/doi.org\/10.1111\/jdv.16415","DOI":"10.1111\/jdv.16415"},{"issue":"3","key":"8886_CR86","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrd1334","volume":"3","author":"SA Ames","year":"2004","unstructured":"Ames SA, Gleeson CD, Kirkpatrick P (2004) Omalizumab. Nat Rev Drug Discov 3(3):199\u2013200. https:\/\/doi.org\/10.1038\/nrd1334","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"8886_CR87","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.jaci.2015.12.1342","volume":"137","author":"Z Zhao","year":"2016","unstructured":"Zhao Z, Ji C, Yu W et al (2016) Omalizumab for the treatment of chronic spontaneous urticaria: a meta-analysis of randomized clinical trials. J Allergy Clin Immunol 137(6):1742-1750.e1744. https:\/\/doi.org\/10.1016\/j.jaci.2015.12.1342","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8886_CR88","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12016-020-08794-6","volume":"59","author":"M Metz","year":"2020","unstructured":"Metz M, Vadasz Z, Kocat\u00fcrk E et al (2020) Omalizumab updosing in chronic spontaneous urticaria: an overview of real-world evidence. Clin Rev Allergy Immunol 59(1):38\u201345. https:\/\/doi.org\/10.1007\/s12016-020-08794-6","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"8886_CR89","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.anai.2019.11.028","volume":"124","author":"AP McIntyre","year":"2020","unstructured":"McIntyre AP, Viswanathan RK, Moss MH et al (2020) Real-world dosing of omalizumab for chronic spontaneous urticaria. Ann Allergy Asthma Immunol 124(2):211\u2013212. https:\/\/doi.org\/10.1016\/j.anai.2019.11.028","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"8886_CR90","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/ced.13173","volume":"42","author":"M Pinto Gouveia","year":"2017","unstructured":"Pinto Gouveia M, Gameiro A, Pinho A et al (2017) Long-term management of chronic spontaneous urticaria with omalizumab. Clin Exp Dermatol 42(7):735\u2013742. https:\/\/doi.org\/10.1111\/ced.13173","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"8886_CR91","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/all.13675","volume":"74","author":"M T\u00fcrk","year":"2019","unstructured":"T\u00fcrk M, Maurer M, Y\u0131lmaz \u0130 (2019) How to discontinue omalizumab in chronic spontaneous urticaria? Allergy 74(4):821\u2013824. https:\/\/doi.org\/10.1111\/all.13675","journal-title":"Allergy"},{"issue":"3","key":"8886_CR92","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.jaci.2017.10.018","volume":"141","author":"M Maurer","year":"2018","unstructured":"Maurer M, Kaplan A, Ros\u00e9n K et al (2018) The XTEND-CIU study: long-term use of omalizumab in chronic idiopathic urticaria. J Allergy Clin Immunol 141(3):1138-1139.e1137. https:\/\/doi.org\/10.1016\/j.jaci.2017.10.018","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8886_CR93","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/j.jaip.2020.02.012","volume":"8","author":"J Sanchez","year":"2020","unstructured":"Sanchez J, Alvarez L, Cardona R (2020) Cyclosporine and omalizumab together: a new option for chronic refractory urticaria. J Allergy Clin Immunol Pract 8(6):2101\u20132103. https:\/\/doi.org\/10.1016\/j.jaip.2020.02.012","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"8886_CR94","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jaci.2016.03.030","volume":"138","author":"P Lieberman","year":"2016","unstructured":"Lieberman P, Umetsu D, Carrigan G et al (2016) Anaphylactic reactions associated with omalizumab administration: analysis of a case-control study. J Allergy Clin Immunol 138(3):913-915.e912. https:\/\/doi.org\/10.1016\/j.jaci.2016.03.030","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8886_CR95","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.jaci.2017.07.013","volume":"140","author":"P Lieberman","year":"2017","unstructured":"Lieberman P, Jones I, Rajwanshi R et al (2017) Anaphylaxis associated with omalizumab administration: risk factors and patient characteristics. J Allergy Clin Immunol 140(6):1734-1736.e1734. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8886_CR96","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2011.04.010","volume":"128","author":"L Cox","year":"2011","unstructured":"Cox L, Lieberman P, Wallace D et al (2011) American Academy of Allergy, Asthma & Immunology\/American College of Allergy, Asthma & Immunology Omalizumab-Associated Anaphylaxis Joint Task Force follow-up report. J Allergy Clin Immunol 128(1):210\u2013212. https:\/\/doi.org\/10.1016\/j.jaci.2011.04.010","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8886_CR97","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1684\/ejd.2018.3454","volume":"29","author":"A Tiotiu","year":"2019","unstructured":"Tiotiu A, Poreaux C, Poncet P et al (2019) Is the high risk of anaphylaxis to omalizumab a contraindication to this treatment? European journal of dermatology: EJD 29(1):101\u2013102. https:\/\/doi.org\/10.1684\/ejd.2018.3454","journal-title":"European journal of dermatology: EJD"},{"issue":"3","key":"8886_CR98","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1172\/jci129697","volume":"130","author":"B Balbino","year":"2020","unstructured":"Balbino B, Herviou P, Godon O et al (2020) The anti-IgE mAb omalizumab induces adverse reactions by engaging Fc\u03b3 receptors. J Clin Investig 130(3):1330\u20131335. https:\/\/doi.org\/10.1172\/jci129697","journal-title":"J Clin Investig"},{"key":"8886_CR99","doi-asserted-by":"publisher","unstructured":"Marzano A, Genovese G, Casazza G et al (2019) Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients. J Eur Acad Dermatol Venereol 33(5):918\u2013924. https:\/\/doi.org\/10.1111\/jdv.15350","DOI":"10.1111\/jdv.15350"},{"issue":"6","key":"8886_CR100","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.jaci.2017.08.007","volume":"140","author":"R Ertas","year":"2017","unstructured":"Ertas R, Ozyurt K, Ozlu E et al (2017) Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria. J Allergy Clin Immunol 140(6):1749\u20131751. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.007","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8886_CR101","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2340\/00015555-2654","volume":"97","author":"G Deza","year":"2017","unstructured":"Deza G, Bertol\u00edn-Colilla M, Pujol R et al (2017) Basophil Fc\u03b5RI expression in chronic spontaneous urticaria: a potential immunological predictor of response to omalizumab therapy. Acta Derm Venereol 97(6):698\u2013704. https:\/\/doi.org\/10.2340\/00015555-2654","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"8886_CR102","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1111\/all.13936","volume":"74","author":"R Asero","year":"2019","unstructured":"Asero R, Marzano A, Ferrucci S et al (2019) Baseline D-dimer plasma levels correlate with disease activity but not with the response to omalizumab in chronic spontaneous urticaria. Allergy 74(12):2538. https:\/\/doi.org\/10.1111\/all.13936","journal-title":"Allergy"},{"issue":"3","key":"8886_CR103","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jaci.2016.07.047","volume":"139","author":"J Gericke","year":"2017","unstructured":"Gericke J, Metz M, Ohanyan T et al (2017) Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria. J Allergy Clin Immunol 139(3):1059-1061.e1051. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.047","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8886_CR104","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.jaci.2016.08.050","volume":"139","author":"P Kolkhir","year":"2017","unstructured":"Kolkhir P, Church M, Weller K et al (2017) Autoimmune chronic spontaneous urticaria: what we know and what we do not know. J Allergy Clin Immunol 139(6):1772-1781.e1771. https:\/\/doi.org\/10.1016\/j.jaci.2016.08.050","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8886_CR105","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/all.14033","volume":"75","author":"R Erta\u015f","year":"2020","unstructured":"Erta\u015f R, Hawro T, Altrichter S et al (2020) Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU. Allergy 75(2):468\u2013470. https:\/\/doi.org\/10.1111\/all.14033","journal-title":"Allergy"},{"key":"8886_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.08.048","author":"Y Oda","year":"2020","unstructured":"Oda Y, Fukunaga A, Washio K et al (2020) Improved Fc\u03b5RI-mediated CD203c basophil responsiveness reflects rapid responses to omalizumab in chronic spontaneous urticaria. J Allergy Clin Immunol Pract. https:\/\/doi.org\/10.1016\/j.jaip.2020.08.048","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"8886_CR107","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.alit.2019.10.009","volume":"69","author":"Y Bae","year":"2020","unstructured":"Bae Y, Kang S, Park J et al (2020) Serum transglutaminase 2 activity as a potential biomarker of disease severity and response to omalizumab in chronic spontaneous urticaria. Allergology international: Official Journal of the Japanese Society of Allergology 69(2):304\u2013306. https:\/\/doi.org\/10.1016\/j.alit.2019.10.009","journal-title":"Allergology international: Official Journal of the Japanese Society of Allergology"},{"key":"8886_CR108","doi-asserted-by":"publisher","unstructured":"Altrichter S, Hawro T, H\u00e4nel K et al (2016) Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels. J Eur Acad Dermatol Venereol 30(3):454\u2013455. https:\/\/doi.org\/10.1111\/jdv.12831","DOI":"10.1111\/jdv.12831"},{"key":"8886_CR109","doi-asserted-by":"publisher","DOI":"10.1111\/all.14702","author":"T Al-Shaikhly","year":"2020","unstructured":"Al-Shaikhly T, MacDonald J, Bammler T et al (2020) Extracellular vesicle microRNAs as predictors of response to omalizumab in chronic spontaneous urticaria. Allergy. https:\/\/doi.org\/10.1111\/all.14702","journal-title":"Allergy"},{"key":"8886_CR110","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19312","author":"J Castagna","year":"2020","unstructured":"Castagna J, Bernard L, Hacard F et al (2020) Clinical predictive factors of unresponsiveness to omalizumab in patients with chronic spontaneous urticaria. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.19312","journal-title":"Br J Dermatol"},{"key":"8886_CR111","doi-asserted-by":"publisher","unstructured":"Al-Shaikhly T, Rosenthal JA, Ayars AG et al (2019) Omalizumab for chronic urticaria in children younger than 12 years. Ann Allergy Asthma Immunol 123(2):208\u2013210.e2. https:\/\/doi.org\/10.1016\/j.anai.2019.05.003","DOI":"10.1016\/j.anai.2019.05.003"},{"key":"8886_CR112","doi-asserted-by":"publisher","DOI":"10.1111\/all.14686","author":"X Song","year":"2020","unstructured":"Song X, Chen Y, Yu M et al (2020) Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study. Allergy. https:\/\/doi.org\/10.1111\/all.14686","journal-title":"Allergy"},{"issue":"2","key":"8886_CR113","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jaci.2014.08.025","volume":"135","author":"J Namazy","year":"2015","unstructured":"Namazy J, Cabana M, Scheuerle A et al (2015) The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol 135(2):407\u2013412. https:\/\/doi.org\/10.1016\/j.jaci.2014.08.025","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8886_CR114","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jaci.2019.05.019","volume":"145","author":"J Namazy","year":"2020","unstructured":"Namazy J, Blais L, Andrews E et al (2020) Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort. J Allergy Clin Immunol 145(2):528-536.e521. https:\/\/doi.org\/10.1016\/j.jaci.2019.05.019","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8886_CR115","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000509179","volume":"12","author":"L Losappio","year":"2020","unstructured":"Losappio L, Mirone C, Schroeder J et al (2020) Omalizumab use in chronic spontaneous urticaria during pregnancy and a four years\u2019 follow-up: a case report. Case Rep Dermatol 12(3):174\u2013177. https:\/\/doi.org\/10.1159\/000509179","journal-title":"Case Rep Dermatol"},{"issue":"4","key":"8886_CR116","first-page":"145","volume":"48","author":"L Cuervo-Pardo","year":"2016","unstructured":"Cuervo-Pardo L, Barcena-Blanch M, Radojicic C (2016) Omalizumab use during pregnancy for CIU: a tertiary care experience. Eur Ann Allergy Clin Immunol 48(4):145\u2013146","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"2","key":"8886_CR117","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","volume":"143","author":"C Grattan","year":"2000","unstructured":"Grattan C, O\u2019Donnell B, Francis D et al (2000) Randomized double-blind study of cyclosporin in chronic \u2018idiopathic\u2019 urticaria. Br J Dermatol 143(2):365\u2013372. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03664.x","journal-title":"Br J Dermatol"},{"issue":"2","key":"8886_CR118","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jaip.2017.07.017","volume":"6","author":"K Kulthanan","year":"2018","unstructured":"Kulthanan K, Chaweekulrat P, Komoltri C et al (2018) Cyclosporine for chronic spontaneous urticaria: a meta-analysis and systematic review. J Allergy Clin Immunol Pract 6(2):586\u2013599. https:\/\/doi.org\/10.1016\/j.jaip.2017.07.017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"8886_CR119","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/bjd.17005","volume":"180","author":"L Santiago","year":"2019","unstructured":"Santiago L, Ferreira B, Ramos L et al (2019) IgE levels are negatively correlated with clinical response to ciclosporin in chronic spontaneous urticaria. Br J Dermatol 180(1):199\u2013200. https:\/\/doi.org\/10.1111\/bjd.17005","journal-title":"Br J Dermatol"},{"issue":"2","key":"8886_CR120","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.alit.2018.09.006","volume":"68","author":"T Endo","year":"2019","unstructured":"Endo T, Toyoshima S, Kanegae K et al (2019) Identification of biomarkers for predicting the response to cyclosporine A therapy in patients with chronic spontaneous urticaria. Allergology international: Official Journal of the Japanese Society of Allergology 68(2):270\u2013273. https:\/\/doi.org\/10.1016\/j.alit.2018.09.006","journal-title":"Allergology international: Official Journal of the Japanese Society of Allergology"},{"issue":"5","key":"8886_CR121","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jaip.2013.06.003","volume":"1","author":"D Khan","year":"2013","unstructured":"Khan D (2013) Alternative agents in refractory chronic urticaria: evidence and considerations on their selection and use. J Allergy Clin Immunol Pract 1(5):433-440.e431. https:\/\/doi.org\/10.1016\/j.jaip.2013.06.003","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8886_CR122","doi-asserted-by":"publisher","unstructured":"Garbayo-Salmons P, Exp\u00f3sito-Serrano V (2020) Chronic spontaneous urticaria refractory to cyclosporine add-on omalizumab successfully treated with methotrexate add-on. Dermatol Ther 33(6):e14469. https:\/\/doi.org\/10.1111\/dth.14469","DOI":"10.1111\/dth.14469"},{"issue":"2","key":"8886_CR123","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4103\/0378-6323.129382","volume":"80","author":"V Sharma","year":"2014","unstructured":"Sharma V, Singh S, Ramam M et al (2014) A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria. Indian J Dermatol Venereol Leprol 80(2):122\u2013128. https:\/\/doi.org\/10.4103\/0378-6323.129382","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"8886_CR124","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jaad.2019.07.097","volume":"82","author":"S Leducq","year":"2020","unstructured":"Leducq S, Samimi M, Bernier C et al (2020) Efficacy and safety of methotrexate versus placebo as add-on therapy to H1 antihistamines for patients with difficult-to-treat chronic spontaneous urticaria: a randomized, controlled trial. J Am Acad Dermatol 82(1):240\u2013243. https:\/\/doi.org\/10.1016\/j.jaad.2019.07.097","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"8886_CR125","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jaad.2011.06.004","volume":"66","author":"A Zimmerman","year":"2012","unstructured":"Zimmerman A, Berger E, Elmariah S et al (2012) The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients. J Am Acad Dermatol 66(5):767\u2013770. https:\/\/doi.org\/10.1016\/j.jaad.2011.06.004","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"8886_CR126","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/j.1365-4632.2006.02655.x","volume":"45","author":"E Shahar","year":"2006","unstructured":"Shahar E, Bergman R, Guttman-Yassky E et al (2006) Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and\/or corticosteroids. Int J Dermatol 45(10):1224\u20131227. https:\/\/doi.org\/10.1111\/j.1365-4632.2006.02655.x","journal-title":"Int J Dermatol"},{"issue":"3","key":"8886_CR127","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/ijd.12536","volume":"54","author":"Y Tal","year":"2015","unstructured":"Tal Y, Toker O, Agmon-Levin N et al (2015) Azathioprine as a therapeutic alternative for refractory chronic urticaria. Int J Dermatol 54(3):367\u2013369. https:\/\/doi.org\/10.1111\/ijd.12536","journal-title":"Int J Dermatol"},{"issue":"6","key":"8886_CR128","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.jaip.2018.12.023","volume":"7","author":"S Dorman","year":"2019","unstructured":"Dorman S, Regan S, Khan D (2019) Effectiveness and safety of oral tacrolimus in refractory chronic urticaria. J Allergy Clin Immunol Pract 7(6):2033-2034.e2031. https:\/\/doi.org\/10.1016\/j.jaip.2018.12.023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"8886_CR129","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/j.1365-2222.2004.02019.x","volume":"34","author":"E Nettis","year":"2004","unstructured":"Nettis E, Colanardi M, Paradiso M et al (2004) Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clinical and experimental allergy: Journal of the British Society for Allergy and Clinical Immunology 34(9):1401\u20131407. https:\/\/doi.org\/10.1111\/j.1365-2222.2004.02019.x","journal-title":"Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology"},{"issue":"3","key":"8886_CR130","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jaci.2004.06.018","volume":"114","author":"G Di Lorenzo","year":"2004","unstructured":"Di Lorenzo G, Pacor M, Mansueto P et al (2004) Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 114(3):619\u2013625. https:\/\/doi.org\/10.1016\/j.jaci.2004.06.018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8886_CR131","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/09546634.2017.1329505","volume":"29","author":"J Holm","year":"2018","unstructured":"Holm J, Ivyanskiy I, Thomsen S (2018) Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence. J Dermatolog Treat 29(1):80\u201397. https:\/\/doi.org\/10.1080\/09546634.2017.1329505","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"8886_CR132","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jaip.2014.06.004","volume":"2","author":"M Morgan","year":"2014","unstructured":"Morgan M, Cooke A, Rogers L et al (2014) Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria. J Allergy Clin Immunol Pract 2(5):601\u2013606. https:\/\/doi.org\/10.1016\/j.jaip.2014.06.004","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8886_CR133","doi-asserted-by":"publisher","unstructured":"Engin B, Ozdemir M (2008) Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 22(4):481\u2013486. https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02510.x","DOI":"10.1111\/j.1468-3083.2007.02510.x"},{"issue":"1","key":"8886_CR134","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/jamadermatol.2018.3715","volume":"155","author":"S Liang","year":"2019","unstructured":"Liang S, Hoffmann R, Peterson E et al (2019) Use of dapsone in the treatment of chronic idiopathic and autoimmune urticaria. JAMA Dermatol 155(1):90\u201395. https:\/\/doi.org\/10.1001\/jamadermatol.2018.3715","journal-title":"JAMA Dermatol"},{"issue":"3","key":"8886_CR135","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2230.1994.tb01168.x","volume":"19","author":"P Todd","year":"1994","unstructured":"Todd P, Samaratunga I, Pembroke A (1994) Screening for glucose-6-phosphate dehydrogenase deficiency prior to dapsone therapy. Clin Exp Dermatol 19(3):217\u2013218. https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01168.x","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"8886_CR136","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jdermsci.2017.08.007","volume":"88","author":"H Watanabe","year":"2017","unstructured":"Watanabe H, Watanabe Y, Tashiro Y et al (2017) A docking model of dapsone bound to HLA-B*13:01 explains the risk of dapsone hypersensitivity syndrome. J Dermatol Sci 88(3):320\u2013329. https:\/\/doi.org\/10.1016\/j.jdermsci.2017.08.007","journal-title":"J Dermatol Sci"},{"issue":"2","key":"8886_CR137","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5935\/0305-7518.19910020","volume":"62","author":"S Byrd","year":"1991","unstructured":"Byrd S, Gelber R (1991) Effect of dapsone on haemoglobin concentration in patients with leprosy. Lepr Rev 62(2):171\u2013178. https:\/\/doi.org\/10.5935\/0305-7518.19910020","journal-title":"Lepr Rev"},{"issue":"5","key":"8886_CR138","doi-asserted-by":"publisher","first-page":"220","DOI":"10.23822\/EurAnnACI.1764-1489.11","volume":"49","author":"T Boonpiyathad","year":"2017","unstructured":"Boonpiyathad T, Sangasapaviliya A (2017) Hydroxychloroquine in the treatment of anti-histamine refractory chronic spontaneous urticaria, randomized single-blinded placebo-controlled trial and an open label comparison study. Eur Ann Allergy Clin Immunol 49(5):220\u2013224. https:\/\/doi.org\/10.23822\/EurAnnACI.1764-1489.11","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"8886_CR139","doi-asserted-by":"publisher","unstructured":"Shi Y, Wang Q, Qiu X et al (2019) [Meta-analysis of efficacy and safety of Tripterygium Glycosides Tablets combined with desloratadine in treatment of chronic urticarial]. Zhongguo Zhong Yao Za Zhi (China Journal of Traditional Chinese Medicine) 44(16):3551\u20133557. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20181112.001","DOI":"10.19540\/j.cnki.cjcmm.20181112.001"},{"key":"8886_CR140","doi-asserted-by":"publisher","unstructured":"Hrabak T, Calabria C (2010) Multiple treatment cycles of high-dose intravenous immunoglobulin for chronic spontaneous urticaria. Ann Allergy Asthma Immunol 105(3):245. https:\/\/doi.org\/10.1016\/j.anai.2010.05.018","DOI":"10.1016\/j.anai.2010.05.018"},{"issue":"5","key":"8886_CR141","first-page":"386","volume":"20","author":"R Asero","year":"2010","unstructured":"Asero R, Tedeschi A (2010) Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. J Investig Allergol Clin Immunol 20(5):386\u2013390","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"5","key":"8886_CR142","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4103\/ijd.IJD_710_16","volume":"62","author":"K Godse","year":"2017","unstructured":"Godse K, Nadkarni N, Patil S et al (2017) Subcutaneous autologous serum therapy in chronic spontaneous urticaria. Indian J Dermatol 62(5):505\u2013507. https:\/\/doi.org\/10.4103\/ijd.IJD_710_16","journal-title":"Indian J Dermatol"},{"issue":"3","key":"8886_CR143","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000458152","volume":"172","author":"N Kitsioulis","year":"2017","unstructured":"Kitsioulis N, Xepapadaki P, Roussaki-Schulze A et al (2017) Effectiveness of autologous whole-blood injections in patients with refractory chronic spontaneous urticaria. Int Arch Allergy Immunol 172(3):161\u2013166. https:\/\/doi.org\/10.1159\/000458152","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"8886_CR144","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/phpp.12008","volume":"29","author":"N Khafagy","year":"2013","unstructured":"Khafagy N, Salem S, Ghaly E (2013) Comparative study of systemic psoralen and ultraviolet A and narrowband ultraviolet B in treatment of chronic urticaria. Photodermatol Photoimmunol Photomed 29(1):12\u201317. https:\/\/doi.org\/10.1111\/phpp.12008","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1","key":"8886_CR145","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/bjd.14778","volume":"176","author":"A Bishnoi","year":"2017","unstructured":"Bishnoi A, Parsad D, Vinay K et al (2017) Phototherapy using narrowband ultraviolet B and psoralen plus ultraviolet A is beneficial in steroid-dependent antihistamine-refractory chronic urticaria: a randomized, prospective observer-blinded comparative study. Br J Dermatol 176(1):62\u201370. https:\/\/doi.org\/10.1111\/bjd.14778","journal-title":"Br J Dermatol"},{"issue":"1","key":"8886_CR146","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jaip.2016.08.010","volume":"5","author":"S Seth","year":"2017","unstructured":"Seth S, Khan D (2017) The comparative safety of multiple alternative agents in refractory chronic urticaria patients. J Allergy Clin Immunol Pract 5(1):165-170.e162. https:\/\/doi.org\/10.1016\/j.jaip.2016.08.010","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"8886_CR147","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/cea.12400","volume":"44","author":"J Arm","year":"2014","unstructured":"Arm J, Bottoli I, Skerjanec A et al (2014) Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects. Clinical and experimental allergy: Journal of the British Society for Allergy and Clinical Immunology 44(11):1371\u20131385. https:\/\/doi.org\/10.1111\/cea.12400","journal-title":"Clinical and experimental allergy: Journal of the British Society for Allergy and Clinical Immunology"},{"issue":"14","key":"8886_CR148","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1900408","volume":"381","author":"M Maurer","year":"2019","unstructured":"Maurer M, Gim\u00e9nez-Arnau A, Sussman G et al (2019) Ligelizumab for chronic spontaneous urticaria. N Engl J Med 381(14):1321\u20131332. https:\/\/doi.org\/10.1056\/NEJMoa1900408","journal-title":"N Engl J Med"},{"issue":"14","key":"8886_CR149","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1056\/NEJMc2016395","volume":"383","author":"J Bernstein","year":"2020","unstructured":"Bernstein J, Singh U, Rao M et al (2020) Benralizumab for chronic spontaneous urticaria. N Engl J Med 383(14):1389\u20131391. https:\/\/doi.org\/10.1056\/NEJMc2016395","journal-title":"N Engl J Med"},{"issue":"5","key":"8886_CR150","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jaip.2018.11.018","volume":"7","author":"J Lee","year":"2019","unstructured":"Lee J, Simpson R (2019) Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria. J Allergy Clin Immunol Pract 7(5):1659-1661.e1651. https:\/\/doi.org\/10.1016\/j.jaip.2018.11.018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"8886_CR151","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/all.12884","volume":"71","author":"M Magerl","year":"2016","unstructured":"Magerl M, Altrichter S, Borzova E et al (2016) The definition, diagnostic testing, and management of chronic inducible urticarias-the EAACI\/GA(2) LEN\/EDF\/UNEV consensus recommendations 2016 update and revision. Allergy 71(6):780\u2013802. https:\/\/doi.org\/10.1111\/all.12884","journal-title":"Allergy"},{"issue":"12","key":"8886_CR152","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1111\/all.13878","volume":"74","author":"M Maurer","year":"2019","unstructured":"Maurer M, Hawro T, Krause K et al (2019) Diagnosis and treatment of chronic inducible urticaria. Allergy 74(12):2550\u20132553. https:\/\/doi.org\/10.1111\/all.13878","journal-title":"Allergy"},{"issue":"2","key":"8886_CR153","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jaip.2016.09.029","volume":"5","author":"J S\u00e1nchez","year":"2017","unstructured":"S\u00e1nchez J, Amaya E, Acevedo A et al (2017) Prevalence of inducible urticaria in patients with chronic spontaneous urticaria: associated risk factors. J Allergy Clin Immunol Pract 5(2):464\u2013470. https:\/\/doi.org\/10.1016\/j.jaip.2016.09.029","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8886_CR154","doi-asserted-by":"publisher","DOI":"10.1111\/all.14674","author":"N Maltseva","year":"2020","unstructured":"Maltseva N, Borzova E, Fomina D et al (2020) Cold urticaria what we know and what we do not know. Allergy. https:\/\/doi.org\/10.1111\/all.14674","journal-title":"Allergy"},{"issue":"2","key":"8886_CR155","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jaip.2015.09.021","volume":"4","author":"P Vadas","year":"2016","unstructured":"Vadas P, Sinilaite A, Chaim M (2016) Cholinergic urticaria with anaphylaxis: an underrecognized clinical entity. J Allergy Clin Immunol Pract 4(2):284\u2013291. https:\/\/doi.org\/10.1016\/j.jaip.2015.09.021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"8886_CR156","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1111\/jdv.13765","volume":"30","author":"S Altrichter","year":"2016","unstructured":"Altrichter S, Koch K, Church M et al (2016) Atopic predisposition in cholinergic urticaria patients and its implications. J Eur Acad Dermatol Venereol JEADV 30(12):2060\u20132065. https:\/\/doi.org\/10.1111\/jdv.13765","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"5","key":"8886_CR157","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.jaip.2018.12.025","volume":"7","author":"G Gastaminza","year":"2019","unstructured":"Gastaminza G, Azofra J, Nunez-Cordoba J et al (2019) Efficacy and safety of omalizumab (Xolair) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: a randomized mixed double-blind and open-label placebo-controlled clinical trial. J Allergy Clin Immunol Pract 7(5):1599-1609.e1591. https:\/\/doi.org\/10.1016\/j.jaip.2018.12.025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8886_CR158","unstructured":"Tanaka T, Ishii K, Suzuki H et al (2007) [Cholinergic urticaria successfully treated by immunotherapy with partially purified sweat antigen] (Article in Japanese). Arerugi (Allergy) 56(1):54\u20137"},{"issue":"1","key":"8886_CR159","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2332\/allergolint.13-OA-0611","volume":"63","author":"M Hiragun","year":"2014","unstructured":"Hiragun M, Hiragun T, Ishii K et al (2014) Elevated serum IgE against MGL_1304 in patients with atopic dermatitis and cholinergic urticaria. Allergology international: Official Journal of the Japanese Society of Allergology 63(1):83\u201393. https:\/\/doi.org\/10.2332\/allergolint.13-OA-0611","journal-title":"Allergology international: Official Journal of the Japanese Society of Allergology"},{"issue":"3","key":"8886_CR160","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.jaci.2017.01.043","volume":"140","author":"M Metz","year":"2017","unstructured":"Metz M, Sch\u00fctz A, Weller K et al (2017) Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial. J Allergy Clin Immunol 140(3):864-867.e865. https:\/\/doi.org\/10.1016\/j.jaci.2017.01.043","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8886_CR161","first-page":"303","volume":"25","author":"J Alba Mar\u00edn","year":"2015","unstructured":"Alba Mar\u00edn J, Martorell Aragones A, Satorre Viejo P et al (2015) Treatment of severe cold-induced urticaria in a child with omalizumab. J Investig Allergol Clin Immunol 25(4):303\u2013304","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4","key":"8886_CR162","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ceca.2010.09.001","volume":"48","author":"Y Cho","year":"2010","unstructured":"Cho Y, Jang Y, Yang Y et al (2010) TRPM8 mediates cold and menthol allergies associated with mast cell activation. Cell Calcium 48(4):202\u2013208. https:\/\/doi.org\/10.1016\/j.ceca.2010.09.001","journal-title":"Cell Calcium"},{"issue":"5","key":"8886_CR163","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ceca.2011.08.003","volume":"50","author":"N Medic","year":"2011","unstructured":"Medic N, Desai A, Komarow H et al (2011) Examination of the role of TRPM8 in human mast cell activation and its relevance to the etiology of cold-induced urticaria. Cell Calcium 50(5):473\u2013480. https:\/\/doi.org\/10.1016\/j.ceca.2011.08.003","journal-title":"Cell Calcium"},{"issue":"8","key":"8886_CR164","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1016\/j.jaip.2020.04.042","volume":"8","author":"Y Oda","year":"2020","unstructured":"Oda Y, Washio K, Fukunaga A et al (2020) Establishment of the basophil activation test to detect photoallergens in solar urticaria. J Allergy Clin Immunol Pract 8(8):2817-2819.e2811. https:\/\/doi.org\/10.1016\/j.jaip.2020.04.042","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"8886_CR165","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1034\/j.1398-9995.2000.00445.x","volume":"55","author":"T Zuberbier","year":"2000","unstructured":"Zuberbier T, Henz B, Fiebiger E et al (2000) Anti-FcepsilonRIalpha serum autoantibodies in different subtypes of urticaria. Allergy 55(10):951\u2013954. https:\/\/doi.org\/10.1034\/j.1398-9995.2000.00445.x","journal-title":"Allergy"},{"issue":"3","key":"8886_CR166","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaci.2017.01.042","volume":"140","author":"M Maurer","year":"2017","unstructured":"Maurer M, Sch\u00fctz A, Weller K et al (2017) Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial. J Allergy Clin Immunol 140(3):870-873.e875. https:\/\/doi.org\/10.1016\/j.jaci.2017.01.042","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8886_CR167","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1365-2133.1987.tb04898.x","volume":"116","author":"G Murphy","year":"1987","unstructured":"Murphy G, Zollman P, Greaves M et al (1987) Symptomatic dermographism (factitious urticaria)\u2013passive transfer experiments from human to monkey. Br J Dermatol 116(6):801\u2013804. https:\/\/doi.org\/10.1111\/j.1365-2133.1987.tb04898.x","journal-title":"Br J Dermatol"},{"issue":"2","key":"8886_CR168","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jaci.2017.06.032","volume":"141","author":"M Maurer","year":"2018","unstructured":"Maurer M, Metz M, Brehler R et al (2018) Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence. J Allergy Clin Immunol 141(2):638\u2013649. https:\/\/doi.org\/10.1016\/j.jaci.2017.06.032","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8886_CR169","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jaip.2014.07.008","volume":"2","author":"H Komarow","year":"2014","unstructured":"Komarow H, Arceo S, Young M et al (2014) Dissociation between history and challenge in patients with physical urticaria. J Allergy Clin Immunol Pract 2(6):786\u2013790. https:\/\/doi.org\/10.1016\/j.jaip.2014.07.008","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8149","key":"8886_CR170","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/s0140-6736(79)92664-3","volume":"2","author":"A Black","year":"1979","unstructured":"Black A, Sibbald R, Greaves M (1979) Cold urticaria treated by induction of tolerance. Lancet (London, England) 2(8149):964. https:\/\/doi.org\/10.1016\/s0140-6736(79)92664-3","journal-title":"Lancet (London, England)"},{"issue":"3","key":"8886_CR171","first-page":"296","volume":"127","author":"M Pont","year":"2000","unstructured":"Pont M, Delaporte E, Bonnevalle A et al (2000) Solar urticaria: pre-PUVA UVA desensitization. Ann Dermatol Venereol 127(3):296\u2013299","journal-title":"Ann Dermatol Venereol"},{"issue":"3","key":"8886_CR172","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2332\/allergolint.10-OA-0269","volume":"60","author":"T Kozaru","year":"2011","unstructured":"Kozaru T, Fukunaga A, Taguchi K et al (2011) Rapid desensitization with autologous sweat in cholinergic urticaria. Allergology international: Official Journal of the Japanese Society of Allergology 60(3):277\u2013281. https:\/\/doi.org\/10.2332\/allergolint.10-OA-0269","journal-title":"Allergology international: Official Journal of the Japanese Society of Allergology"},{"issue":"2","key":"8886_CR173","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-2133.1975.tb03057.x","volume":"92","author":"I Leigh","year":"1975","unstructured":"Leigh I, Ramsay C (1975) Localized heat urticaria treated by inducing tolerance to heat. Br J Dermatol 92(2):191\u2013194. https:\/\/doi.org\/10.1111\/j.1365-2133.1975.tb03057.x","journal-title":"Br J Dermatol"},{"issue":"5","key":"8886_CR174","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.jaci.2018.01.031","volume":"141","author":"C Dressler","year":"2018","unstructured":"Dressler C, Werner R, Eisert L et al (2018) Chronic inducible urticaria: a systematic review of treatment options. J Allergy Clin Immunol 141(5):1726\u20131734. https:\/\/doi.org\/10.1016\/j.jaci.2018.01.031","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8886_CR175","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jaci.2019.02.005","volume":"143","author":"K Kulthanan","year":"2019","unstructured":"Kulthanan K, Hunnangkul S, Tuchinda P et al (2019) Treatments of cold urticaria: a systematic review. J Allergy Clin Immunol 143(4):1311\u20131331. https:\/\/doi.org\/10.1016\/j.jaci.2019.02.005","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8886_CR176","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.jaip.2020.03.004","volume":"8","author":"K Kulthanan","year":"2020","unstructured":"Kulthanan K, Ungprasert P, Tuchinda P et al (2020) Delayed pressure urticaria: a systematic review of treatment options. J Allergy Clin Immunol Pract 8(6):2035-2049.e2035. https:\/\/doi.org\/10.1016\/j.jaip.2020.03.004","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"8886_CR177","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1016\/j.jaip.2020.05.016","volume":"8","author":"K Kulthanan","year":"2020","unstructured":"Kulthanan K, Ungprasert P, Tuchinda P et al (2020) Symptomatic dermographism: a systematic review of treatment options. J Allergy Clin Immunol Pract 8(9):3141\u20133161. https:\/\/doi.org\/10.1016\/j.jaip.2020.05.016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"8886_CR178","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jdermsci.2017.02.283","volume":"87","author":"E Kocat\u00fcrk","year":"2017","unstructured":"Kocat\u00fcrk E, Can P, Akbas P et al (2017) Management of chronic inducible urticaria according to the guidelines: a prospective controlled study. J Dermatol Sci 87(1):60\u201369. https:\/\/doi.org\/10.1016\/j.jdermsci.2017.02.283","journal-title":"J Dermatol Sci"},{"issue":"3","key":"8886_CR179","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jaad.2015.11.021","volume":"74","author":"F Aubin","year":"2016","unstructured":"Aubin F, Avenel-Audran M, Jeanmougin M et al (2016) Omalizumab in patients with severe and refractory solar urticaria: a phase II multicentric study. J Am Acad Dermatol 74(3):574\u2013575. https:\/\/doi.org\/10.1016\/j.jaad.2015.11.021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"8886_CR180","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jaci.2018.08.050","volume":"143","author":"S Altrichter","year":"2019","unstructured":"Altrichter S, Chuamanochan M, Knoth H et al (2019) Real-life treatment of cholinergic urticaria with omalizumab. J Allergy Clin Immunol 143(2):788-791.e788. https:\/\/doi.org\/10.1016\/j.jaci.2018.08.050","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8886_CR181","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jaip.2018.02.032","volume":"6","author":"I Snast","year":"2018","unstructured":"Snast I, Kremer N, Lapidoth M et al (2018) Omalizumab for the treatment of solar urticaria: case series and systematic review of the literature. J Allergy Clin Immunol Pract 6(4):1198-1204.e1193. https:\/\/doi.org\/10.1016\/j.jaip.2018.02.032","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8886_CR182","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19425","author":"V Exposito-Serrano","year":"2020","unstructured":"Exposito-Serrano V, Curto-Barredo L, Aguilera Peiro P et al (2020) Omalizumab for the treatment of chronic inducible urticaria in 80 patients. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.19425","journal-title":"Br J Dermatol"},{"issue":"1","key":"8886_CR183","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/bjd.14820","volume":"176","author":"M Gorczyza","year":"2017","unstructured":"Gorczyza M, Schoepke N, Krause K et al (2017) Patients with chronic cold urticaria may benefit from doxycycline therapy. Br J Dermatol 176(1):259\u2013261. https:\/\/doi.org\/10.1111\/bjd.14820","journal-title":"Br J Dermatol"},{"issue":"4","key":"8886_CR184","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jaad.2006.04.078","volume":"55","author":"G Vena","year":"2006","unstructured":"Vena G, Cassano N, Colombo D et al (2006) Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 55(4):705\u2013709. https:\/\/doi.org\/10.1016\/j.jaad.2006.04.078","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"8886_CR185","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.anai.2017.07.029","volume":"119","author":"R Koski","year":"2017","unstructured":"Koski R, Kennedy K (2017) Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria. Ann. Allergy Asthma Immunol. 119(5):397\u2013401. https:\/\/doi.org\/10.1016\/j.anai.2017.07.029","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"4","key":"8886_CR186","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.anai.2019.01.006","volume":"122","author":"M Weinberger","year":"2019","unstructured":"Weinberger M (2019) Another look at cyclosporine for treating antihistamine-resistant chronic spontaneous urticaria. Ann. Allergy Asthma Immunol. 122(4):425\u2013427. https:\/\/doi.org\/10.1016\/j.anai.2019.01.006","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"5","key":"8886_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2019.100033","volume":"12","author":"YS Pathania","year":"2019","unstructured":"Pathania YS, Bishnoi A, Parsad D et al (2019) Comparing azathioprine with cyclosporine in the treatment of antihistamine refractory chronic spontaneous urticaria: a randomized prospective active-controlled non-inferiority study. World Allergy Organ J 12(5):100033. https:\/\/doi.org\/10.1016\/j.waojou.2019.100033","journal-title":"World Allergy Organ J"},{"issue":"3","key":"8886_CR188","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/2229-5178.156391","volume":"6","author":"D Bhanja","year":"2015","unstructured":"Bhanja D, Ghoshal L, Das S et al (2015) Azathioprine in autologous serum skin test positive chronic urticaria: a case-control study in a tertiary care hospital of eastern India. Indian Dermatol Online J 6(3):185\u2013188. https:\/\/doi.org\/10.4103\/2229-5178.156391","journal-title":"Indian Dermatol Online J"},{"issue":"10","key":"8886_CR189","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/archderm.142.10.1337","volume":"142","author":"L McGirt","year":"2006","unstructured":"McGirt L, Vasagar K, Gober L et al (2006) Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol 142(10):1337\u20131342. https:\/\/doi.org\/10.1001\/archderm.142.10.1337","journal-title":"Arch Dermatol"},{"issue":"1","key":"8886_CR190","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.anai.2013.09.028","volume":"112","author":"R Orden","year":"2014","unstructured":"Orden R, Timble H, Saini S (2014) Efficacy and safety of sulfasalazine in patients with chronic idiopathic urticaria. Ann. Allergy Asthma Immunol. 112(1):64\u201370. https:\/\/doi.org\/10.1016\/j.anai.2013.09.028","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"3","key":"8886_CR191","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1067\/mai.2002.126676","volume":"110","author":"Z Erbagci","year":"2002","unstructured":"Erbagci Z (2002) The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 110(3):484\u2013488. https:\/\/doi.org\/10.1067\/mai.2002.126676","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8886_CR192","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jaip.2018.04.026","volume":"6","author":"A Akenroye","year":"2018","unstructured":"Akenroye A, McEwan C, Saini S (2018) Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria. J Allergy Clin Immunol Pract 6(4):1403\u20131405. https:\/\/doi.org\/10.1016\/j.jaip.2018.04.026","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"8886_CR193","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.anai.2009.12.007","volume":"104","author":"H Mitzel-Kaoukhov","year":"2010","unstructured":"Mitzel-Kaoukhov H, Staubach P, M\u00fcller-Brenne T (2010) Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria. Ann. Allergy Asthma Immunol. 104(3):253\u2013258. https:\/\/doi.org\/10.1016\/j.anai.2009.12.007","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"3","key":"8886_CR194","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/000155500750043131","volume":"80","author":"M Kroiss","year":"2000","unstructured":"Kroiss M, Vogt T, Landthaler M et al (2000) The effectiveness of low-dose intravenous immunoglobulin in chronic urticaria. Acta Derm Venereol 80(3):225. https:\/\/doi.org\/10.1080\/000155500750043131","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"8886_CR195","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2340\/00015555-0434","volume":"88","author":"B Engin","year":"2008","unstructured":"Engin B, Ozdemir M, Balevi A et al (2008) Treatment of chronic urticaria with narrowband ultraviolet B phototherapy: a randomized controlled trial. Acta Derm Venereol 88(3):247\u2013251. https:\/\/doi.org\/10.2340\/00015555-0434","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"8886_CR196","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3109\/09546634.2011.593485","volume":"23","author":"E Kocat\u00fcrk","year":"2012","unstructured":"Kocat\u00fcrk E, Akta\u015f S, T\u00fcrko\u011flu Z et al (2012) Autologous whole blood and autologous serum injections are equally effective as placebo injections in reducing disease activity in patients with chronic spontaneous urticaria: a placebo controlled, randomized, single-blind study. J Dermatolog Treat 23(6):465\u2013471. https:\/\/doi.org\/10.3109\/09546634.2011.593485","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"8886_CR197","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/cea.13102","volume":"48","author":"J Ruft","year":"2018","unstructured":"Ruft J, Asady A, Staubach P et al (2018) Development and validation of the Cholinergic Urticaria Quality-of-Life Questionnaire (CholU-QoL). Clinical and experimental allergy: Journal of the British Society for Allergy and Clinical Immunology 48(4):433\u2013444. https:\/\/doi.org\/10.1111\/cea.13102","journal-title":"Clinical and experimental allergy: Journal of the British Society for Allergy and Clinical Immunology"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08886-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08886-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08886-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T22:14:30Z","timestamp":1640643270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08886-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":197,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8886"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08886-x","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"11 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Informed Consent"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}